within Pharmacolibrary.Drugs.ATC.R;

model R03BB03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 1.0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,
    adminCount     = 1,
    Vd             = 0.0026,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Stramoni preparations are derived from the plant Datura stramonium, containing tropane alkaloids such as atropine, hyoscyamine, and scopolamine. Historically, they were used as bronchodilators in the treatment of asthma and other respiratory disorders, primarily in the form of inhaled powders or cigarettes. Due to significant toxicity and safer alternatives, such preparations are no longer in common or approved therapeutic use.</p><h4>Pharmacokinetics</h4><p>No clinical pharmacokinetic studies or precise population data for stramoni preparations as a mixture exist; parameter estimates are extrapolated from known pharmacokinetics of the major tropane alkaloid component (atropine) in healthy adult subjects following inhaled administration.</p><h4>References</h4><ol><li><p>Irvine, J, et al., &amp; Islam, N (2018). Formulation and delivery strategies of ibuprofen: challenges and opportunities. <i>Drug development and industrial pharmacy</i> 44(2) 173–183. DOI:<a href=&quot;https://doi.org/10.1080/03639045.2017.1391838&quot;>10.1080/03639045.2017.1391838</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29022772/&quot;>https://pubmed.ncbi.nlm.nih.gov/29022772</a></p></li><li><p>Nováková, A, et al., &amp; Slanař, O (2022). Factors Affecting Drug Exposure after Inhalation. <i>Prague medical report</i> 123(3) 129–139. DOI:<a href=&quot;https://doi.org/10.14712/23362936.2022.13&quot;>10.14712/23362936.2022.13</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36107443/&quot;>https://pubmed.ncbi.nlm.nih.gov/36107443</a></p></li><li><p>Yue, P, et al., &amp; Yang, M (2022). Nanocrystals based pulmonary inhalation delivery system: advance and challenge. <i>Drug delivery</i> 29(1) 637–651. DOI:<a href=&quot;https://doi.org/10.1080/10717544.2022.2039809&quot;>10.1080/10717544.2022.2039809</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35188021/&quot;>https://pubmed.ncbi.nlm.nih.gov/35188021</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R03BB03;
